Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

Use of Fertility Preservation Services in Female Reproductive-Aged Cancer Patients.

Selter J, Huang Y, Grossman Becht LC, Palmerola KL, Williams SZ, Forman E, Ananth CV, Hur C, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2019 May 17. pii: S0002-9378(19)30667-2. doi: 10.1016/j.ajog.2019.05.009. [Epub ahead of print]

PMID:
31108063
2.

Neuronal Protection for Chemotherapy Neuropathy Prevention?

Loprinzi CL, Hershman DL, Staff N.

J Natl Cancer Inst. 2019 May 15. pii: djz088. doi: 10.1093/jnci/djz088. [Epub ahead of print] No abstract available.

PMID:
31093679
3.

Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer.

Wright JD, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL.

Obstet Gynecol. 2019 May 9. doi: 10.1097/AOG.0000000000003288. [Epub ahead of print]

PMID:
31083126
4.

Safety of Same Day Discharge for Minimally Invasive Hysterectomy for Endometrial Cancer.

Praiss AM, Chen L, St Clair CM, Tergas AI, Khoury-Collado F, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2019 May 10. pii: S0002-9378(19)30658-1. doi: 10.1016/j.ajog.2019.05.003. [Epub ahead of print]

PMID:
31082381
5.

Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy.

Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih YT, Chavez-MacGregor M, Duan Z, Giordano SH, Hershman DL, Fisch MJ, Cantor SB.

JCO Clin Cancer Inform. 2019 Mar;3:1-12. doi: 10.1200/CCI.18.00097.

6.

FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data.

Neugut AI, Lin A, Raab GT, Hillyer GC, Keller D, O'Neil DS, Accordino MK, Kiran RP, Wright J, Hershman DL.

Clin Colorectal Cancer. 2019 Jan 31. pii: S1533-0028(18)30611-X. doi: 10.1016/j.clcc.2019.01.005. [Epub ahead of print]

PMID:
30878317
7.

Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.

Henry NL, Unger JM, Till C, Schott AF, Crew KD, Lew DL, Fisch MJ, Moinpour CM, Wade JL 3rd, Hershman DL.

Cancer. 2019 Mar 12. doi: 10.1002/cncr.32024. [Epub ahead of print]

PMID:
30861098
8.

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.

Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME.

J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221.

9.

Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.

Baglia ML, Lin IH, Cartmel B, Sanft T, Ligibel J, Hershman DL, Harrigan M, Ferrucci LM, Li FY, Irwin ML.

Cancer. 2019 Mar 6. doi: 10.1002/cncr.32051. [Epub ahead of print]

PMID:
30840336
10.

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.

Heilbroner SP, Xanthopoulos EP, Buono D, Huang Y, Carrier D, Shah A, Kim J, Corradetti M, Wright JD, Neugut AI, Hershman DL, Cheng SK.

Lung Cancer. 2019 Mar;129:8-15. doi: 10.1016/j.lungcan.2018.12.021. Epub 2018 Dec 24.

PMID:
30797496
11.

Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.

Cham S, Chen L, St Clair CM, Hou JY, Tergas AI, Melamed A, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2019 Feb 13. pii: S0002-9378(19)30360-6. doi: 10.1016/j.ajog.2019.02.019. [Epub ahead of print]

PMID:
30771346
12.

Patterns of care and outcomes for women with uterine cancer and ovarian metastases.

Jones NL, Huang Y, Chatterjee S, Tergas AI, Burke WM, Hou JY, Deutsch I, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Int J Gynecol Cancer. 2019 Feb;29(2):365-376. doi: 10.1136/ijgc-2018-000047. Epub 2019 Jan 4.

PMID:
30718315
13.

Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.

Leng S, Chen Y, Tsai WY, Bhutani D, Hillyer GC, Lim E, Accordino MK, Wright JD, Hershman DL, Lentzsch S, Neugut AI.

J Natl Compr Canc Netw. 2019 Jan;17(1):22-28. doi: 10.6004/jnccn.2018.7079.

PMID:
30659126
14.

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.

Ramsey SD, Unger JM, Baker LH, Little RF, Loomba R, Hwang JP, Chugh R, Konerman MA, Arnold K, Menter AR, Thomas E, Michels RM, Jorgensen CW, Burton GV, Bhadkamkar NA, Hershman DL.

JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6437. [Epub ahead of print] Erratum in: JAMA Oncol. 2019 Mar 7;:.

PMID:
30653226
15.

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.

Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL.

JAMA Netw Open. 2018 Aug 3;1(4):e181235. doi: 10.1001/jamanetworkopen.2018.1235.

16.

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.

Unger JM, Hershman DL, Fleury ME, Vaidya R.

JAMA Oncol. 2019 Jan 10. doi: 10.1001/jamaoncol.2018.5953. [Epub ahead of print] Erratum in: JAMA Oncol. 2019 Feb 14;:.

PMID:
30629092
17.

Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.

Hershman DL, Unger JM, Crew K.

JAMA. 2018 Dec 4;320(21):2270-2271. doi: 10.1001/jama.2018.16744. No abstract available.

PMID:
30512095
18.

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).

Mongiovi JM, Zirpoli GR, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Thomas Budd G, Albain KS, Ambrosone CB, McCann SE.

Breast Cancer Res. 2018 Nov 28;20(1):146. doi: 10.1186/s13058-018-1077-9.

19.

Factors Associated With Follow-Up Care Among Women With Early-Stage Breast Cancer.

Quyyumi FF, Wright JD, Accordino MK, Buono D, Law CW, Hillyer GC, Neugut AI, Hershman DL.

J Oncol Pract. 2019 Jan;15(1):e1-e9. doi: 10.1200/JOP.18.00229. Epub 2018 Nov 8.

PMID:
30407882
20.

Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients.

Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, Falcone DJ, Winston LA, Zhou XK, Hudis CA, Hershman DL, Dannenberg AJ, Iyengar NM.

Cancer Prev Res (Phila). 2019 Jan;12(1):21-30. doi: 10.1158/1940-6207.CAPR-18-0207. Epub 2018 Nov 7.

PMID:
30404870
21.

A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer.

Blanco C, Markowitz JC, Hellerstein DJ, Nezu AM, Wall M, Olfson M, Chen Y, Levenson J, Onishi M, Varona C, Okuda M, Hershman DL.

Breast Cancer Res Treat. 2019 Jan;173(2):353-364. doi: 10.1007/s10549-018-4994-5. Epub 2018 Oct 20.

PMID:
30343455
22.

Regional Market Competition and the Use of Immediate Breast Reconstruction After Mastectomy.

Wright JD, Chen L, Accordino M, Taback B, Ananth CV, Neugut AI, Hershman DL.

Ann Surg Oncol. 2019 Jan;26(1):62-70. doi: 10.1245/s10434-018-6825-7. Epub 2018 Oct 16.

PMID:
30327971
23.

Effect of Minimum-Volume Standards on Patient Outcomes and Surgical Practice Patterns for Hysterectomy.

Ruiz MP, Chen L, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Obstet Gynecol. 2018 Nov;132(5):1229-1237. doi: 10.1097/AOG.0000000000002912.

PMID:
30303921
24.

Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008).

Greenlee H, Lew DL, Hershman DL, Newman VA, Hansen L, Hartman SJ, Korner J, Shi Z, Sardo Molmenti CL, Sayegh A, Fehrenbacher L, Lo S, Klemp J, Rinn K, Robertson JM, Unger J, Gralow J, Albain K, Krouse R, Fabian C.

Obesity (Silver Spring). 2018 Oct;26(10):1539-1549. doi: 10.1002/oby.22269. Epub 2018 Sep 11.

PMID:
30272836
25.

National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.

Seidman AD, Bordeleau L, Fehrenbacher L, Barlow WE, Perlmutter J, Rubinstein L, Wedam SB, Hershman DL, Hayes JF, Butler LP, Smith ML, Regan MM, Beaver JA, Amiri-Kordestani L, Rastogi P, Zujewski JA, Korde LA.

J Clin Oncol. 2018 Sep 13:JCO1800242. doi: 10.1200/JCO.18.00242. [Epub ahead of print]

PMID:
30212295
26.

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL 3rd, Fisch MJ, Henry NL, Hershman DL.

Breast Cancer Res Treat. 2018 Dec;172(3):603-610. doi: 10.1007/s10549-018-4946-0. Epub 2018 Aug 29.

PMID:
30159789
27.

Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers.

Nieto VL, Huang Y, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2018 Nov;219(5):463.e1-463.e12. doi: 10.1016/j.ajog.2018.07.028. Epub 2018 Aug 4.

PMID:
30086293
28.

Reply to T.P. Houston et al.

Hershman DL, Unger JM.

J Clin Oncol. 2018 Sep 20;36(27):2810-2811. doi: 10.1200/JCO.18.00285. Epub 2018 Jul 23. No abstract available.

PMID:
30036115
29.

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study.

Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD.

Cancer Med. 2018 Sep;7(9):4251-4260. doi: 10.1002/cam4.1657. Epub 2018 Jul 20.

30.

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.

Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD.

JAMA. 2018 Jul 10;320(2):167-176. doi: 10.1001/jama.2018.8907.

PMID:
29998338
31.

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.

Unger JM, Barlow WE, Tangen CM, Ramsey SD, Thompson IM Jr, Klein EA, LeBlanc M, Blanke CD, Goodman PJ, Minasian LM, Nghiem VT, Hershman DL.

Cancer Epidemiol. 2018 Aug;55:117-122. doi: 10.1016/j.canep.2018.06.005. Epub 2018 Jun 21.

PMID:
29936140
32.

Changes in Surgical Volume and Outcomes Over Time for Women Undergoing Hysterectomy for Endometrial Cancer.

Wright JD, Ruiz MP, Chen L, Gabor LR, Tergas AI, St Clair CM, Hou JY, Ananth CV, Neugut AI, Hershman DL.

Obstet Gynecol. 2018 Jul;132(1):59-69. doi: 10.1097/AOG.0000000000002691.

PMID:
29889759
33.

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline.

Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L.

J Clin Oncol. 2018 Sep 1;36(25):2647-2655. doi: 10.1200/JCO.2018.79.2721. Epub 2018 Jun 11.

PMID:
29889605
34.

Utilization of ovarian transposition for fertility preservation among young women with pelvic malignancies who undergo radiotherapy.

Selter J, Grossman Becht LC, Huang Y, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2018 Oct;219(4):415-417. doi: 10.1016/j.ajog.2018.05.037. Epub 2018 Jun 6. No abstract available.

PMID:
29883577
35.

Assessment of Electronic Alert to Reduce Overuse of Granulocyte Colony-Stimulating Factor in Patients Hospitalized for Febrile Neutropenia.

Accordino MK, Wright JD, Vasan S, Buono DL, Hu JC, Neugut AI, Hershman DL.

JAMA Oncol. 2018 Jul 1;4(7):996-998. doi: 10.1001/jamaoncol.2018.0818. No abstract available.

36.

Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions.

Agrawal S, Chen L, Tergas AI, Hou JY, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2018 Jul;219(1):89.e1-89.e15. doi: 10.1016/j.ajog.2018.05.001. Epub 2018 May 8.

PMID:
29750957
37.

Trends in Use and Survival Associated With Fertility-Sparing Trachelectomy for Young Women With Early-Stage Cervical Cancer.

Cui RR, Chen L, Tergas AI, Hou JY, St Clair CM, Neugut AI, Ananth CV, Hershman DL, Wright JD.

Obstet Gynecol. 2018 Jun;131(6):1085-1094. doi: 10.1097/AOG.0000000000002613.

PMID:
29742670
38.

Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons.

Ruiz MP, Chen L, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Obstet Gynecol. 2018 Jun;131(6):981-990. doi: 10.1097/AOG.0000000000002597.

PMID:
29742669
39.

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial.

Kalinsky K, Sparano JA, Zhong X, Andreopoulou E, Taback B, Wiechmann L, Feldman SM, Ananthakrishnan P, Ahmad A, Cremers S, Sireci AN, Cross JR, Marks DK, Mundi P, Connolly E, Crew KD, Maurer MA, Hibshoosh H, Lee S, Hershman DL.

Clin Transl Oncol. 2018 Nov;20(11):1474-1483. doi: 10.1007/s12094-018-1888-2. Epub 2018 May 7.

PMID:
29736694
40.

A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.

Deverka PA, Bangs R, Kreizenbeck K, Delaney DM, Hershman DL, Blanke CD, Ramsey SD.

J Natl Cancer Inst. 2018 Jun 1;110(6):553-559. doi: 10.1093/jnci/djy064.

41.

Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.

Kroenke CH, Hershman DL, Gomez SL, Adams SR, Eldridge EH, Kwan ML, Ergas IJ, Kubo A, Kushi LH.

Breast Cancer Res Treat. 2018 Aug;170(3):623-631. doi: 10.1007/s10549-018-4774-2. Epub 2018 Apr 18.

PMID:
29671113
42.

Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials.

Hershman DL, Till C, Shen S, Wright JD, Ramsey SD, Barlow WE, Unger JM.

J Clin Oncol. 2018 Sep 10;36(26):2710-2717. doi: 10.1200/JCO.2017.77.4414. Epub 2018 Mar 27.

PMID:
29584550
43.

Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma.

Gómez-Hidalgo NR, Chen L, Hou JY, Tergas AI, St Clair CM, Ananth CV, Hershman DL, Wright JD.

Cancer Invest. 2018 Mar 16;36(3):190-198. doi: 10.1080/07357907.2018.1449212. Epub 2018 Mar 22.

44.

Identifying modifiable and non-modifiable risk factors associated with prolonged length of stay after hysterectomy for uterine cancer.

Agrawal S, Chen L, Tergas AI, Hou JY, St Clair CM, Ananth CV, Hershman DL, Wright JD.

Gynecol Oncol. 2018 Jun;149(3):545-553. doi: 10.1016/j.ygyno.2018.03.048. Epub 2018 Mar 17.

PMID:
29559171
45.

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

Zirpoli GR, McCann SE, Sucheston-Campbell LE, Hershman DL, Ciupak G, Davis W, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS, Ambrosone CB.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx098.

46.

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

Unger JM, Hershman DL, Till C, Tangen CM, Barlow WE, Ramsey SD, Goodman PJ, Thompson IM Jr.

J Natl Cancer Inst. 2018 Nov 1;110(11):1208-1215. doi: 10.1093/jnci/djy035.

47.

Impact of hospital volume on racial disparities and outcomes for endometrial cancer.

Buskwofie A, Huang Y, Tergas AI, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Gynecol Oncol. 2018 May;149(2):329-336. doi: 10.1016/j.ygyno.2018.02.019. Epub 2018 Mar 2.

48.

Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast Cancer.

Gunther JE, Lim EA, Kim HK, Flexman M, Altoé M, Campbell JA, Hibshoosh H, Crew KD, Kalinsky K, Hershman DL, Hielscher AH.

Radiology. 2018 Jun;287(3):778-786. doi: 10.1148/radiol.2018161041. Epub 2018 Feb 12.

PMID:
29431574
49.

Use and impact of herpes zoster prophylaxis in myeloma patients treated with proteasome inhibitors.

Leng S, Lentzsch S, Shen Y, Tsai WY, Wright JD, Hershman DL, Neugut AI.

Leuk Lymphoma. 2018 Oct;59(10):2465-2469. doi: 10.1080/10428194.2018.1429605. Epub 2018 Feb 2. No abstract available.

50.

Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.

Chavez-MacGregor M, Unger JM, Moseley A, Ramsey SD, Hershman DL.

Cancer. 2018 Apr 15;124(8):1760-1769. doi: 10.1002/cncr.31241. Epub 2018 Jan 25.

Supplemental Content

Loading ...
Support Center